ArticleJournal of immunotherapy (Hagerstown, Md. : 1997)2025

Brief Communication: Combination of an MIP3α-Antigen Fusion Therapeutic DNA Vaccine With Treatments of IFNα and 5-Aza-2'Deoxycytidine Enhances Activated Effector CD8+ T Cells Expressing CD11c in the B16F10 Melanoma Model.

Kaitlyn Fessler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.